Cargando…
Redefining tuberculosis: an interview with Lalita Ramakrishnan
Professor Lalita Ramakrishnan is at the forefront of modern tuberculosis (TB) research. She has developed vital tools, most notably a robust zebrafish model, to study this disease, leading to seminal discoveries uncovering bacterial and host interactions throughout infection. Her group has harnessed...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073006/ https://www.ncbi.nlm.nih.gov/pubmed/36951140 http://dx.doi.org/10.1242/dmm.050189 |
_version_ | 1785019498322984960 |
---|---|
author | Ramakrishnan, Lalita |
author_facet | Ramakrishnan, Lalita |
author_sort | Ramakrishnan, Lalita |
collection | PubMed |
description | Professor Lalita Ramakrishnan is at the forefront of modern tuberculosis (TB) research. She has developed vital tools, most notably a robust zebrafish model, to study this disease, leading to seminal discoveries uncovering bacterial and host interactions throughout infection. Her group has harnessed this knowledge to develop new treatments for TB and shape clinical research. By unveiling these complex interactions, they have also improved our understanding of fundamental biology of macrophages and other infectious diseases, such as leprosy. |
format | Online Article Text |
id | pubmed-10073006 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-100730062023-04-05 Redefining tuberculosis: an interview with Lalita Ramakrishnan Ramakrishnan, Lalita Dis Model Mech A Model for Life Professor Lalita Ramakrishnan is at the forefront of modern tuberculosis (TB) research. She has developed vital tools, most notably a robust zebrafish model, to study this disease, leading to seminal discoveries uncovering bacterial and host interactions throughout infection. Her group has harnessed this knowledge to develop new treatments for TB and shape clinical research. By unveiling these complex interactions, they have also improved our understanding of fundamental biology of macrophages and other infectious diseases, such as leprosy. The Company of Biologists Ltd 2023-03-23 /pmc/articles/PMC10073006/ /pubmed/36951140 http://dx.doi.org/10.1242/dmm.050189 Text en © 2023. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | A Model for Life Ramakrishnan, Lalita Redefining tuberculosis: an interview with Lalita Ramakrishnan |
title | Redefining tuberculosis: an interview with Lalita Ramakrishnan |
title_full | Redefining tuberculosis: an interview with Lalita Ramakrishnan |
title_fullStr | Redefining tuberculosis: an interview with Lalita Ramakrishnan |
title_full_unstemmed | Redefining tuberculosis: an interview with Lalita Ramakrishnan |
title_short | Redefining tuberculosis: an interview with Lalita Ramakrishnan |
title_sort | redefining tuberculosis: an interview with lalita ramakrishnan |
topic | A Model for Life |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073006/ https://www.ncbi.nlm.nih.gov/pubmed/36951140 http://dx.doi.org/10.1242/dmm.050189 |
work_keys_str_mv | AT ramakrishnanlalita redefiningtuberculosisaninterviewwithlalitaramakrishnan |